News
FDA fast-tracks Sanofi's gene therapy for eye disease GA
Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy, a major cause of blindness.
News
AstraZeneca sifts for efficacy crumbs in amyloidosis trial
AstraZeneca's light chain (AL) amyloidosis candidate anselamimab has failed a phase 3 readout, but showed efficacy in a patient subgroup.
News
MSD, AZ partner LaNova bought by Sino Biopharm for $951m
LaNova Medicines is being bought out by minority shareholder Sino Biopharm in a deal valued at around $951 million.
R&D
Medicine’s blind spot: How clinical trials are failing women
From insulin to immunotherapies, clinical trials have powered some of the most important medical breakthroughs of our time.
R&D
Ben Sidders on integrating causality in AI for R&D success
Ben Sidders, chief scientific officer at Biorelate, discusses leveraging advanced data science methods to transform the focus and impact of R&D.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks